Recently, Lai et al. identified a mechanism by which miR-128 is likely targeting Rad51 directly and leading to the increased DNA damage response in OCI-AML3 and MV4-11 AML cell lines. The gene discussed is RUNX2; the disease is acute myeloid leukemia.